인쇄하기
취소
|
The Korea Food and Drug Administration announced that licenses for new products totaled 19 as of the end of last April. Details:
Status of new products
Product Remarks |
Company |
Indications |
Remarks |
Cresto tab. |
AstraZeneca Korea |
Hyperlipemia |
Clinical use |
Spiriva(tiopropium) |
Boehringer Ingelheim Korea |
COPD |
Clinical use |
Well tab. (buprepi... |